Kiora Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPRX and other ETFs, options, and stocks.About KPRX
Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102.
KPRX Key Statistics
Stock Snapshot
With a market cap of 7.69M, Kiora Pharmaceuticals(KPRX) trades at $2.08. The stock has a price-to-earnings ratio of -0.85.
On 2026-02-15, Kiora Pharmaceuticals(KPRX) stock moved within a range of $2.08 to $2.11. With shares now at $2.08, the stock is trading 0.0% above its intraday low and -1.2% below the session's peak.
Trading activity shows a volume of 8.27K, compared to an average daily volume of 61.81K.
Over the past 52 weeks, Kiora Pharmaceuticals(KPRX) stock has traded between a high of $4.18 and a low of $1.76.
Over the past 52 weeks, Kiora Pharmaceuticals(KPRX) stock has traded between a high of $4.18 and a low of $1.76.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.